Starsita-50
Description_Effects
Starsita-50 contains Sitagliptin 50 mg, an oral anti-diabetic medicine used in the management of Type 2 Diabetes Mellitus. It belongs to a class of drugs called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors), which work by increasing the levels of natural hormones called incretins in the body. Incretins help regulate blood sugar by increasing insulin release from the pancreas and decreasing glucose production by the liver, especially after meals. Sitagliptin acts in a glucose-dependent manner, meaning it works only when blood sugar levels are elevated, thus minimizing the risk of hypoglycemia (low blood sugar), which is a common concern with many diabetes medications. Starsita-50 is often prescribed as part of a broader treatment plan that includes a healthy diet, regular physical activity, and weight management. It may be used alone or in combination with other anti-diabetic medicines such as Metformin or Sulfonylureas. The goal of using Starsita-50 is to improve long-term blood sugar control and prevent complications associated with uncontrolled diabetes, such as nerve damage (neuropathy), kidney issues (nephropathy), eye problems (retinopathy), and cardiovascular diseases. It is generally well tolerated, with a low risk of side effects like weight gain or hypoglycemia. However, it should always be used under medical supervision, with regular blood sugar monitoring.
